OP0017 THERAPEUTIC DRUG MONITORING COMPARED TO STANDARD TREATMENT OF PATIENTS STARTING INFLIXIMAB THERAPY: RESULTS FROM A MULTICENTRE RANDOMISED TRIAL OF 400 PATIENTS
S. W. Syversen, Guro Løvik Goll, K. K. Jørgensen, Øystein Sandanger, J. Sexton, Inge Christoffer Olsen, Johanna Elin Gehin, Marthe Kirkesæther Brun, David J. Warren, Cato Mørk, T.K. Kvien, Jørgen Jahnsen, Nils Bolstad, Espen A. Haavardsholm
Topics & Concepts
MedicineTherapeutic drug monitoringInfliximabUlcerative colitisSulfasalazineRheumatoid arthritisInternal medicinePsoriatic arthritisClinical endpointRandomized controlled trialDiseasePharmacokineticsChronic Lymphocytic Leukemia ResearchSystemic Lupus Erythematosus ResearchBiosimilars and Bioanalytical Methods